FDA Approves RSV Monoclonal Antibody for Infants and Young Children

JAMA. 2023 Aug 15;330(7):586. doi: 10.1001/jama.2023.13137.
No abstract available

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Antiviral Agents* / therapeutic use
  • Child
  • Child, Preschool
  • Drug Approval*
  • Humans
  • Infant
  • Respiratory Syncytial Virus Infections* / drug therapy
  • Respiratory Syncytial Virus Infections* / prevention & control
  • Respiratory Syncytial Virus, Human*
  • United States

Substances

  • Antibodies, Monoclonal
  • Antiviral Agents